Lisata Therapeutics, Inc. (LSTA)
5.01
-0.01
(-0.20%)
USD |
NASDAQ |
Mar 25, 16:00
5.02
+0.01
(+0.20%)
After-Hours: 20:00
Lisata Therapeutics Cash from Investing (Quarterly) : 0.00 for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Penumbra, Inc. | -225.65M |
| Protalix Biotherapeutics, Inc. | -1.112M |
| PAVmed, Inc. | -0.003M |
| Agenus, Inc. | 0.78M |
| Curis, Inc. | 2.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.249M |
| Cash from Financing (Quarterly) | 0.205M |
| Free Cash Flow | -15.98M |
| Free Cash Flow Per Share (Quarterly) | -0.3678 |
| Free Cash Flow to Equity (Quarterly) | -3.249M |
| Free Cash Flow to Firm (Quarterly) | -3.249M |
| Free Cash Flow Yield | -36.68% |